[Contribution of molecular genetics in cavernous angiomas]

Area of Science:

• Neurology
• Genetics
• Molecular Biology

Context:

• Central nervous system (CNS) cavernomas are vascular malformations.
• Approximately 20% of CNS cavernoma cases are linked to autosomal dominant inheritance.
• Multiple lesions and affected parentage are indicative of familial forms.

Purpose:

• To clarify the role of genetic testing in diagnosing and counseling for CNS cavernomas.
• To differentiate between sporadic and familial forms of the disease.
• To inform clinical practice regarding molecular testing utility.

Summary:

• Three genes (CCM1, CCM2, CCM3) associated with familial CNS cavernomas have been identified.
• Molecular testing is not recommended for sporadic cases with a single lesion.
• Genetic tests are valuable for counseling in familial cases and for diagnosing the genetic basis of sporadic multiple lesions.

Impact:

• Provides clear guidelines for the clinical application of genetic testing in CNS cavernomas.
• Aids in accurate diagnosis and genetic counseling for patients and families.
• Contributes to understanding the genetic underpinnings of cerebral angiogenesis.